MRK vs INCY
By Alex · Tickerpine
Merck & Co., Inc. vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | INCY |
|---|---|---|
| Price | $147.76 | $120.97 |
| Market cap | $364.26B | $24.66B |
| P/E ratio | 149.3 | 61.7 |
| ROE | 5.06% | 7.84% |
| Profit margin | 3.64% | 6.71% |
| Revenue growth | 4.70% | 14.00% |
| Dividend yield | 2.30% | 0.00% |
| Beta | 0.12 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs INCY in plain English
- MRK is the bigger company — about 14.8× the market cap of INCY.
- INCY is cheaper on earnings (P/E 61.7 vs 149.3).
- INCY earns a higher return on equity (8% vs 5%).
- INCY is growing revenue faster (14% vs 5%).
- MRK pays a dividend (2.30%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.